UPDATE : Tuesday, January 22, 2019
L&K Biomed gets FDA nod for sacroiliac joint disease implant system
L&K Biomed has received the U.S. Food and Drug Administration’s approval We...
by Marian Chu  |  2018-07-18 16:26
SK Bioscience to expand vaccine production facility
SK Bioscience is pursuing its growth strategy by expanding its vaccine prod...
by Marian Chu  |  2018-07-18 16:13
ViroMed secures DNA production plant in US
ViroMed said Wednesday it acquired a DNA production facility in San Diego, ...
by Marian Chu  |  2018-07-18 15:02
Dong-A ST’s Jublia dominates athlete’s foot drugs
The sales of Dong-A ST’s Jublia, a toenail fungal treatment, has grown rapi...
by So Jae-hyeon  |  2018-07-18 11:50
Novo Nordisk Korea gets nod for diabetes drug Fiasp
Novo Nordisk Korea got the Ministry of Food and Drug Safety’s approval for ...
by Marian Chu  |  2018-07-18 11:50
‘Koreans increasingly seeking out hair loss treatment’
The number of Koreans in their 40s getting hair loss treatments is increasi...
by Marian Chu  |  2018-07-17 16:08
YD Life Science to proceed with P2 trial for diabetic retinopathy treatment
YD Life Science said it got the U.S. Food and Drug Administration’s go-ahea...
by Lee Han-soo  |  2018-07-17 14:52
30% of psoriasis patients take more than 5 years to find correct therapy
Psoriasis patients see an average of three doctors and try four types of tr...
by Marian Chu  |  2018-07-17 14:52
Pharmbio launched CINV treatment
Pharmbio Korea said Tuesday that it has released a prefilled syringe versio...
by Lee Han-soo  |  2018-07-17 14:02
Korean eye drops selling well overseas
Korean eye drops made by Huons, Sam Chun Dang Pharm, and Hanlim Pharm are i...
by So Jae-hyeon  |  2018-07-17 11:36
Multinational pharma focus on P3 trials; locals have more P1 trials
Multinational pharmaceutical firms had more phase 3 trials underway in Kore...
by Marian Chu  |  2018-07-17 11:27
Access Bio signs $1.12-mil. contract for malaria diagnostic test
Access Bio is expanding its reach into Africa with its malaria rapid diagno...
by Marian Chu  |  2018-07-16 16:23
FDA nods Qurient’s multidrug-resistant TB treatment for P2 clinical trials
Qurient said Monday that the U.S. Food and Drug Administration (FDA) has ap...
by Lee Han-soo  |  2018-07-16 15:10
Korean take more drugs than OECD average
Koreans take more medications than most other members of the Organization f...
by Lee Han-soo  |  2018-07-16 12:37
Japanese drugmakers in Korea showed robust performances last year
Japanese multinational pharmaceutical companies have continued to show robu...
by Lee Han-soo  |  2018-07-13 16:32
Samsung BioLogics violated accounting standards: SFC
The Securities and Futures Commission (SFC) said Thursday it has concluded ...
by Lee Han-soo  |  2018-07-12 18:36
Edarbi, Saxenda prescribed in major hospitals
A new hypertension drug Edarbi by Takeda Pharmaceuticals Korea and Dong-A S...
by So Jae-hyeon  |  2018-07-11 15:42
‘Invossa-K will get US approval in 3 years, mark billion dollar sales’
Kolon Tissuegene is accelerating its advance into the U.S. to attain visibl...
by Lee Han-soo  |  2018-07-10 17:01
Orders for original drugs spike amid ban of Chinese valsartan
With the government’s ban on the import and sale of generic drugs containin...
by Park Gi-taek  |  2018-07-10 16:03
Shire launches new Hemophilia A treatment in Korea
Adynovate Shire Korea, the local branch of the global biotech pharmaceuti...
by Lee Han-soo  |  2018-07-10 13:51
Back to Top